866-997-4948(US-Canada Toll Free)

Hypothyroidism - Pipeline Review, H2 2017

Published By :

Global Markets Direct

Published Date : Nov 2017

Category :

Pharmaceutical

No. of Pages : 30 Pages

Hypothyroidism - Pipeline Review, H2 2017

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Hypothyroidism - Pipeline Review, H2 2017, provides an overview of the Hypothyroidism (Hormonal Disorders) pipeline landscape.

Hypothyroidism (underactive thyroid) is a condition in which thyroid gland doesnt produce enough of certain important hormones. Signs and symptom include fatigue, constipation, dry skin, puffy face, muscle weakness, muscle aches, tenderness and stiffness, pain and stiffness. Risk factors include autoimmune diseases, thyroid surgery, radiation therapy and family history of thyroid disease.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Hypothyroidism - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Hypothyroidism (Hormonal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hypothyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypothyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, IND/CTA Filed and Preclinical stages are 1, 1 and 5 respectively.

Hypothyroidism (Hormonal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Hypothyroidism (Hormonal Disorders).
- The pipeline guide reviews pipeline therapeutics for Hypothyroidism (Hormonal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Hypothyroidism (Hormonal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Hypothyroidism (Hormonal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Hypothyroidism (Hormonal Disorders)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Hypothyroidism (Hormonal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Hypothyroidism (Hormonal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Hypothyroidism - Overview 5
Hypothyroidism - Therapeutics Development 6
Pipeline Overview 6
Pipeline by Companies 7
Products under Development by Companies 8
Hypothyroidism - Therapeutics Assessment 9
Assessment by Target 9
Assessment by Mechanism of Action 11
Assessment by Route of Administration 13
Assessment by Molecule Type 15
Hypothyroidism - Companies Involved in Therapeutics Development 17
Genexine Inc 17
Synthonics Inc 17
Titan Pharmaceuticals Inc 17
Hypothyroidism - Drug Profiles 19
(levothyroxine sodium + liothyronine sodium) - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
BCT-305 - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
GX-30 - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
levothyroxine sodium SR - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
liothyronine - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
liothyronine sodium SR - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
liothyronine sodium SR - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
Hypothyroidism - Dormant Projects 26
Hypothyroidism - Product Development Milestones 27
Featured News & Press Releases 27
Oct 19, 2017: Titan Pharmaceuticals Presents Non-Clinical Data From Liothyronine (L-T3) Implant Studies 27
Nov 16, 2015: Titan Pharmaceuticals Adds Proneura Implant For Hypothyroidism To Product Development Pipeline 27
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 29
Disclaimer 30

List of Tables
Number of Products under Development for Hypothyroidism, H2 2017 6
Number of Products under Development by Companies, H2 2017 7
Products under Development by Companies, H2 2017 8
Number of Products by Stage and Target, H2 2017 10
Number of Products by Stage and Mechanism of Action, H2 2017 12
Number of Products by Stage and Route of Administration, H2 2017 14
Number of Products by Stage and Molecule Type, H2 2017 16
Hypothyroidism - Pipeline by Genexine Inc, H2 2017 17
Hypothyroidism - Pipeline by Synthonics Inc, H2 2017 17
Hypothyroidism - Pipeline by Titan Pharmaceuticals Inc, H2 2017 18
Hypothyroidism - Dormant Projects, H2 2017 26

List of Figures
Number of Products under Development for Hypothyroidism, H2 2017 6
Number of Products under Development by Companies, H2 2017 7
Number of Products by Targets, H2 2017 9
Number of Products by Stage and Targets, H2 2017 9
Number of Products by Mechanism of Actions, H2 2017 11
Number of Products by Stage and Mechanism of Actions, H2 2017 11
Number of Products by Routes of Administration, H2 2017 13
Number of Products by Stage and Routes of Administration, H2 2017 13
Number of Products by Molecule Types, H2 2017 15
Number of Products by Stage and Molecule Types, H2 2017 15

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *